These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21991283)

  • 1. The heterogeneity of "major depression".
    Goldberg D
    World Psychiatry; 2011 Oct; 10(3):226-8. PubMed ID: 21991283
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Genetic Analysis Subdivided by Adversity Exposure Suggests Etiologic Heterogeneity in Major Depression.
    Peterson RE; Cai N; Dahl AW; Bigdeli TB; Edwards AC; Webb BT; Bacanu SA; Zaitlen N; Flint J; Kendler KS
    Am J Psychiatry; 2018 Jun; 175(6):545-554. PubMed ID: 29495898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies.
    Cai N; Choi KW; Fried EI
    Hum Mol Genet; 2020 Sep; 29(R1):R10-R18. PubMed ID: 32568380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and Consequences of Diagnostic Heterogeneity in Depression: Paths to Discovering Novel Biological Depression Subtypes.
    Lynch CJ; Gunning FM; Liston C
    Biol Psychiatry; 2020 Jul; 88(1):83-94. PubMed ID: 32171465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Decomposition of Depression Heterogeneity on the Person-, Symptom- and Time-Level: The Use of Three-Mode Principal Component Analysis.
    Monden R; Wardenaar KJ; Stegeman A; Conradi HJ; de Jonge P
    PLoS One; 2015; 10(7):e0132765. PubMed ID: 26177365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decomposing the heterogeneity of depression at the person-, symptom-, and time-level: latent variable models versus multimode principal component analysis.
    de Vos S; Wardenaar KJ; Bos EH; Wit EC; de Jonge P
    BMC Med Res Methodol; 2015 Oct; 15():88. PubMed ID: 26471992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis.
    de Maat SM; Dekker J; Schoevers RA; de Jonghe F
    Eur Psychiatry; 2007 Jan; 22(1):1-8. PubMed ID: 17194571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of developing major depression among individuals with subthreshold depression: a systematic review and meta-analysis of longitudinal cohort studies.
    Lee YY; Stockings EA; Harris MG; Doi SAR; Page IS; Davidson SK; Barendregt JJ
    Psychol Med; 2019 Jan; 49(1):92-102. PubMed ID: 29530112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vitamin D supplementation in major depression: A meta-analysis of randomized controlled trials.
    Vellekkatt F; Menon V
    J Postgrad Med; 2019; 65(2):74-80. PubMed ID: 29943744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of depression in myocardial infarction: A PRISMA-compliant meta-analysis.
    Feng L; Li L; Liu W; Yang J; Wang Q; Shi L; Luo M
    Medicine (Baltimore); 2019 Feb; 98(8):e14596. PubMed ID: 30813183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposition locus for major depression at chromosome 12q22-12q23.2.
    Abkevich V; Camp NJ; Hensel CH; Neff CD; Russell DL; Hughes DC; Plenk AM; Lowry MR; Richards RL; Carter C; Frech GC; Stone S; Rowe K; Chau CA; Cortado K; Hunt A; Luce K; O'Neil G; Poarch J; Potter J; Poulsen GH; Saxton H; Bernat-Sestak M; Thompson V; Gutin A; Skolnick MH; Shattuck D; Cannon-Albright L
    Am J Hum Genet; 2003 Dec; 73(6):1271-81. PubMed ID: 14606042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in perinatal depression: how far have we come? A systematic review.
    Santos H; Tan X; Salomon R
    Arch Womens Ment Health; 2017 Feb; 20(1):11-23. PubMed ID: 27796597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample heterogeneity in unipolar depression as assessed by functional connectivity analyses is dominated by general disease effects.
    Feder S; Sundermann B; Wersching H; Teuber A; Kugel H; Teismann H; Heindel W; Berger K; Pfleiderer B
    J Affect Disord; 2017 Nov; 222():79-87. PubMed ID: 28679115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome variation between depression symptom combinations in the STAR*D study.
    Olbert CM; Rasmussen A; Gala GJ; Tupler LA
    J Affect Disord; 2016 Sep; 201():1-7. PubMed ID: 27155023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of chemokines in major depression.
    Eyre HA; Air T; Pradhan A; Johnston J; Lavretsky H; Stuart MJ; Baune BT
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jul; 68():1-8. PubMed ID: 26903140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of depression characterized by different cognitive decline and brain activity alterations.
    Yang X; Qi S; Wang M; Calhoun VD; Sui J; Li T; Ma X
    J Psychiatr Res; 2021 Jun; 138():413-419. PubMed ID: 33962128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting long-term depression outcome using a three-mode principal component model for depression heterogeneity.
    Monden R; Stegeman A; Conradi HJ; de Jonge P; Wardenaar KJ
    J Affect Disord; 2016 Jan; 189():1-9. PubMed ID: 26398565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Representing the heterogeneity of depression in treatment research.
    Lorenzo-Luaces L
    Acta Psychiatr Scand; 2018 Oct; 138(4):360-361. PubMed ID: 30062768
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity in symptom profiles among older adults diagnosed with major depression.
    Hybels CF; Blazer DG; Landerman LR; Steffens DC
    Int Psychogeriatr; 2011 Aug; 23(6):906-22. PubMed ID: 21241529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiological heterogeneity of symptom dimensions of adolescent depression.
    Chen J; Yu J; Zhang L; Li X; Zhang J
    Psych J; 2014 Dec; 3(4):254-63. PubMed ID: 26272117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.